New copycat bone drug enters human testing
NCT ID NCT07384104
Summary
This early-stage study aims to see if a new drug called SAL023 acts similarly in the body to an existing osteoporosis drug, Evenity. It will involve 118 healthy Chinese adults who will receive a single injection of one of the drugs. Researchers will primarily measure how the body absorbs and processes the drugs, and check for safety and immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Hospital of Anhui Medical University Clinical Pharmacology Research Center
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.